NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DAYLI Partners

DAYLI Partners

Seoul, Seouldayli.partners

Overview

DAYLI Partners is a venture capital firm in South Korea that specializes in venture investments in the pharmaceutical, healthcare, and biotechnology sectors . The firm creates sustainable value by spearheading industry evolution and innovation .

Year Founded

2014

Portfolio Companies

38

Investments

DAYLI Partners investments
CompanyDateStageLead
SN BioScienceApr 2026Growth EquityCo-investor
BreezeBioFeb 2026Series BCo-investor
GeditFeb 2026Series BCo-investor
GaluxFeb 2026Series BCo-investor
1ST Biotherapeutics, Inc.Jan 2026Series DCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSeoul, Seoul
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.